Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small‐cell lung cancer patients treated with first‐line platinum‐containing chemotherapy

BACKGROUND: The current study aimed to evaluate the serum pretreatment lactate dehydrogenase (LDH) and overall survival (OS) in small cell lung cancer (SCLC) patients who received first‐line platinum‐containing chemotherapy. METHODS: A total of 234 SCLC patients, who received first‐line platinum‐bas...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Man, Chi, Xiaorui, Shi, Xinyan, Sun, Yang, Yang, Xue, Wang, Leirong, Wang, Bingrui, Li, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636211/
https://www.ncbi.nlm.nih.gov/pubmed/34725930
http://dx.doi.org/10.1111/1759-7714.13581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636211/
https://www.ncbi.nlm.nih.gov/pubmed/34725930
http://dx.doi.org/10.1111/1759-7714.13581

Ejemplares similares